Correlation between the renal C1q deposition and serum anti-C1q antibody: A potential role of anti-C1q antibody in lupus nephritis

Asian Pacific Journal of Allergy and Immunology

Volumn 20, Issue 4, 2002, Pages 223-227

  Chen, Pei Chih ^b   Wang, Chrong Reen ^a   Liu, Ming Fei ^a   Chen, Fen Fen ^c   Liang, Chun Ching ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Chi Mei Light Technology Co   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; CREATININE; DNA ANTIBODY; DOUBLE STRANDED DNA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMMUNE COMPLEX DEPOSITION; KIDNEY BIOPSY; KIDNEY PARENCHYMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS; WORLD HEALTH ORGANIZATION;

ADULT; AUTOANTIBODIES; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE;

EID: 0038637907     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wisnieski JJ, Jones SM. IgG autoantibodies of collagen-like region of C1q in hypocomplemetemic urticarial vasculitis syndrome, systemic lupus erythemato sus and 6 other musculoskeletal or rheumatic disease. J Rheumatol 1992; 19: 884-8.
2. Bernstein KA, Kahl LE, Balow JE, Lefkowith JB. Serologic markers of lupus nephritis in patients: Use of a tissue-based ELISA and evidence of immunopathogenic heterogeneity. Clin Exp Immunol 1994; 98: 60-5.
3. Gunnarsson I, Ronnelid J, Huang YH, Nilsson, SRB, Lundberg I, Klareskog L. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 1997; 36: 32-7.
4. Siegert CE, Daha MR, Tseng CM, Coremans IEM, Van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus; Ann Rheum Dis 1993; 52: 851-6.
5. Coremans IEM, Spronk PE, Bootsma H, Daha MR, Van Der Voort EAM, Kater L, et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus; Am J Kidney Dis 1995; 26: 595-601.
6. Moroni G, Trendelenburg M, Del Para N, Quaglini S, Raschi E, Panzeri P, et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 37: 490-8.
7. Sjöholm AG, Martensson U, Sturfelt G. Serial analysis of autoantibody responses to the collagen-like region of C1q, collage type II, and double stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 871-8.
8. Hay FC, Nineham LJ, Roit IM, et al. Routine assay for the detection of immune complexes of known immunogbulin class using solid phase C1q. Clin Exp Immunol 1976; 24: 396-400.
9. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 30: 104-16.
10. Uwatoko S, Mannik M. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to collagen-like region of C1q. J Clin Invest 1988; 82: 816-24.
11. Antes U, Heinz HP, Loos M. Evidence of the presence of autoantibodies to the collagen-like protein of C1q in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 457-64.
12. Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 1997; 40: 1504-11.
13. Pickering MC, Walport MJ. Link between complement abnormalities and systemic lupus erythematosus. Rheumatology 2000; 39: 133-41.
14. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997; 158: 4525-28.
15. Kishore U, Reid KB. C1q: Structure, function, and receptors; Immunopharmacology 2000; 49: 159-70.
16. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-9.
17. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, et al. A hierarchical role of classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192: 359-66.
18. Siegert CEH, Kazatchkine MD, Sjöholm A, Würzner R, Loos M, Daha MR, et al. Autoantibodies against C1q: View on clinical relevance and pathogenic roles. Clin Exp Immunol 1999; 116: 4-8.